Kevin Obrien
Allergy & Immunology · Thornton, CONPI 1134131733
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Biocryst Pharmaceuticals, Inc. at 58.5% of the total. Reporting peaked in 2019 at $6,543 and has fallen 92.4% since, to $500 in 2022.
Across 189 payments — averaging $67.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biocryst Pharmaceuticals, Inc.$8K
- Biocryst US Sales Co., LLC$2K
- Sanofi$623
- GSK$551
- AstraZeneca$380
- Grifols USA, LLC$347
- plus $1K from 26 others
Across 3,337 payments — averaging $514.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$1.5M
- Biocryst Pharmaceuticals, Inc.$125K
- Exeltis, USA Inc.$60K
- Amgen$23K
- AbbVie$21K
What the payments were for
- Consulting fees$3,76529%
- Speaking & faculty fees$5,00039%
- Travel & lodging$9007%
- Food & beverage$3,16125%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biocryst Pharmaceuticals, Inc. | 15 | $7,507 |
| Biocryst US Sales Co., LLC | 12 | $2,010 |
| Sanofi | 18 | $623 |
| GSK | 36 | $551 |
| AstraZeneca | 23 | $380 |
| Grifols USA, LLC | 16 | $347 |
| Regeneron Healthcare Solutions, Inc. | 18 | $319 |
| CSL Behring | 11 | $277 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $180 |
| Novartis | 6 | $104 |
| Stryker | 1 | $48 |
| Sanofi-aventis U.S. LLC | 2 | $45 |
| Paratek Pharmaceuticals, Inc. | 2 | $41 |
| Pfizer | 2 | $37 |
| Octapharma USA, Inc. | 1 | $35 |
| Nestle Healthcare Nutrition Inc. | 2 | $31 |
| Genentech USA, Inc. | 2 | $29 |
| Johnson & Johnson | 2 | $25 |
| Lundbeck LLC | 1 | $21 |
| Kaleo, Inc. | 1 | $20 |
| Amgen | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| AbbVie | 1 | $18 |
| Circassia Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Incyte Corporation | 1 | $16 |
| Eyevance Pharmaceuticals LLC | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Optinose US, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,826 in reported general payments places this provider in the 75th percentile of 89 allergy & immunology providers in Colorado.
Other allergy & immunology in Thornton
- Rohit KatialDenver$758K
- Nicole BarberisLakewood$351K
- Christopher WebberColorado Springs$350K
- Jeffrey RumbyrtLakewood$348K
- Eric CaplanColorado Springs$290K
- Eileen WangDenver$274K
- Donald LeungDenver$208K
- Robert NathanColorado Springs$130K
- Katherine McCormackLouisville$90K
- Flavia HoyteDenver$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.